Drug as contaminants of emerging concert: preventive approaches beyond detection, regulatory aspect and remediation
Cancelli U, Quarta E, D’Angelo D, Bazzoli G, Bianchera A, Bettini R. Sci Tot Engment 2025 Sept 10. doi: https://doi.org/10.1016/j.scitotenv.2025.180411
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects
D’angelo D, Quarta E, Bazzoli G, Bianchera A, Bettini R. Int J Pharm 2025 Jan 5, doi: 10.1016/j.ijpharm.2024.125014
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
Bianchera A, Vilardo V, Giaccari R, Michielon A, Bazzoli G, Buttini F, Aiello M, Chetta A, Bruno S, Bettini R. Deliv Transl Res. 2023 Apr 25. doi: 10.1007/s13346-023-01346-3
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept
Bianchera A, Alomari E, Michielon A, Bazzoli G, Ronda N, Pighini G, Zanotti I, Giorgio C, Mozzarelli A, Bettini R, Bruno S.; Pharmaceutics 2022 Dec 8;14(12):2754. doi: 10.3390/pharmaceutics14122754.
An engineered anti-idiotypic antibody-derived killer peptide (KP) induces early activation of swine inflammatory monocytes, NKT cells and double positive CD4+CD8 + cytotoxic T lymphocyte (DP CTL) subsets in association with TNF-a and IFN-ɣ secretion.
Ferrari L, Martelli P, Saleri R, De Angelis E, Ferrarini G, Cavalli V, Passeri B, Bazzoli G, Ogno G, Magliani W, Borghetti P. Comp Immunol Microbiol Infect Dis. 2020 Oct;72:101523. doi: 10.1016/j.cimid.2020.101523.
